Zim Laboratories (ZIMLA) Share Price near 52-Week High as ZIMLA Trades at Rs 145.20
- October 7, 2026
- Posted by: Chaitanya Auti
- Category: News
Zim Laboratories Share Price is in focus as ZIMLA traded at Rs 145.20, up 4.84% from the previous session, and stayed close to its 52-week high during morning trade on 07 October 2026 at 1:22 PM IST. The company’s market capitalisation stood at Rs 731.1 Cr, placing Zim Laboratories Share Price Today among the more closely watched names in the Pharmaceuticals & Drugs space. According to latest Univest data, the move is relevant because the stock is trading near its yearly high, but the latest Univest figures do not establish a company-specific catalyst. For readers tracking Zim Laboratories Stock News, the key questions are how far the price moved from the previous close, what the day’s range shows, and whether the current valuation still leaves room for interpretation in a sector benchmark that can be compared with peers.
Zim Laboratories Share Price also matters because it combines a near 52-week high event with a high absolute valuation multiple, a modest book-value multiple and a market cap that sits below the sector median. Univest data confirms the price event, while the broader reading comes from the company’s own financial ratios and same-industry comparisons. In Zim Laboratories Share Price News, that combination is often what keeps the stock on screens: a sharp daily move, a near one-year high, and a set of fundamentals that can be judged against the Healthcare sector and listed peers.
Zim Laboratories Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 145.2 |
| Previous Close | Rs 138.5 |
| Today's Move | +Rs 6.7 (+4.84%) |
| Open | Rs 139 |
| High | Rs 152 |
| Low | Rs 136.8 |
| Market Capitalisation | Rs 731.1 crore |
Zim Laboratories Ltd. (ZIMLA) traded at Rs 145.2 versus the previous close of Rs 138.5, a rise of 4.84%. The stock opened at Rs 139, reached a high of Rs 152 and touched a low of Rs 136.8.
Zim Laboratories Share Price Today reflected a firm move from the previous close of Rs 138.5 to Rs 145.2, a gain of Rs 6.7 or 4.84%. Zim Laboratories Share Price opened at Rs 139 and moved within a range of Rs 136.8 to Rs 152 during the reported time window. That leaves Zim Laboratories Share Price close to the upper end of the day’s range, with the current trade sitting Rs 6.8 below the day high. The latest Univest data also places ZIMLA near its 52-week high, which is why Zim Laboratories Share Price Update has drawn attention in Zim Laboratories Stock News and Zim Laboratories Share Price Live searches. What exactly happened today is straightforward: the stock moved higher in intraday trade and remained near its yearly high without any verified company-specific trigger identified by the latest Univest figures.
For readers following Zim Laboratories Share Price Today, the price action is best read as a near-peak market event rather than a commentary on any fresh corporate announcement. The move from Rs 138.5 to Rs 145.2 is measurable, the day’s high at Rs 152 shows the upper bound reached in trade, and the current level remains within sight of the 52-week high theme that defines 52 Week High Stocks on Stock Market Today screens. In Zim Laboratories Share News, the evidence is price-based and factual, not narrative-based.
Zim Laboratories Share Price therefore becomes a stock to track for its latest trade location, not for an asserted reason. The verified numbers show a strong day move against the previous close, a day range that tested higher levels, and a price standing close to the yearly high. Zim Laboratories Share Price Today remains the cleanest way to frame the session before moving to fundamental analysis.
Zim Laboratories Ltd. (ZIMLA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 731.1 crore |
| P/E Ratio | 201.07x |
| P/B Ratio | 2.56x |
| ROE | 2.14% |
| ROCE | 5.47% |
| EPS | Rs 0.69 |
| Book Value Per Share | Rs 54.16 |
| Dividend Yield | 0% |
Zim Laboratories Ltd. (ZIMLA) fundamental metrics show P/E 201.07x, P/B 2.56x, ROE 2.14%, ROCE 5.47%. These figures provide context only and are not a buy or sell signal.
Zim Laboratories Ltd. has a market capitalisation of Rs 731.1 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 201.07x, P/B at 2.56x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 2.14% and ROCE of 5.47%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 0.69, book value per share of Rs 54.16, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 28.27x, median ROE of 11.73%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 201.07x |
| Benchmark Median P/E | 28.27x |
| Benchmark Average P/E | 40.34x |
| Benchmark P/E Range | 0x to 695.67x |
| Company P/B Ratio | 2.56x |
| Benchmark Median P/B | 2.9x |
| Company ROE | 2.14% |
| Benchmark Median ROE | 11.73% |
| Company ROCE | 5.47% |
| Benchmark Median ROCE | 13.63% |
| Company Market Capitalisation | Rs 731.1 crore |
| Benchmark Median Market Cap | Rs 833.16 crore |
Zim Laboratories Ltd. (ZIMLA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Zim Laboratories Ltd. (ZIMLA) has a P/E ratio of 201.07x, which is above the benchmark median of 28.27x, a difference of +611.25%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Zim Laboratories Ltd. (ZIMLA) has a ROE of 2.14%, which is below the benchmark median of 11.73%, a difference of -81.76%. Zim Laboratories Ltd. (ZIMLA) has a ROCE of 5.47%, which is below the benchmark median of 13.63%, a difference of -59.87%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Amanta Healthcare Ltd. | AMANTA | 763.39 | 52.02 | 3.42 | 9.4 | 11.23 |
| Valiant Laboratories Ltd. | VALIANTLAB | 681.62 | 42.4 | 2.04 | -0.93 | -0.4 |
| Wanbury Ltd. | WANBURY | 661.92 | 12.34 | 4.7 | 67.87 | 30.31 |
| Kilitch Drugs (India) Ltd. | KILITCH | 816.35 | 30.4 | 3.25 | 12.26 | 14.5 |
| HEXAGON NUTRITION LIMITED | HEXAGON | 849.98 | 22.84 | 3.57 | 14.11 | 17.37 |
Zim Laboratories Ltd. (ZIMLA) has a P/E ratio of 201.07x compared with the displayed peer median of 30.4x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 2.14% compares with a peer median of 12.26% across the companies shown in the table. ROCE stood at 5.47% versus the displayed peer median of 14.5%, providing a capital-efficiency comparison. Zim Laboratories Ltd. (ZIMLA) has a market capitalisation of Rs 731.1 crore. Among the 5 peers shown, 3 have a larger market capitalisation.
Why Investors Are Watching Zim Laboratories Share Price
- Zim Laboratories Share Price traded at Rs 145.20, up 4.84% from the previous close of Rs 138.5.
- Zim Laboratories Share Price stayed near its 52-week high during the reported trade window.
- Zim Laboratories Share Price carries a P/E ratio of 201.07 and a P/B ratio of 2.56.
- Zim Laboratories Share Price shows ROE of 2.14% and ROCE of 5.47% in the latest figures.
- Zim Laboratories Share Price is below the industry median market capitalisation of Rs 833.16 Cr at Rs 731.1 Cr.
About Zim Laboratories
Zim Laboratories Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. Zim Laboratories Share Price reflects a listed company in a same-industry set where valuation, return ratios and market capitalisation can be compared directly with other pharmaceutical names. Zim Laboratories Stock News often appears in the context of benchmark comparison because the company’s trading level, market capitalisation and financial ratios can all be read against a large peer universe. Zim Laboratories Share Price Today therefore sits within a broader industry frame rather than an isolated price print.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.
Frequently Asked Questions
Why is Zim Laboratories Share Price in focus today?
Ans. Zim Laboratories Share Price is in focus because it traded at Rs 145.20, rose 4.84% from the previous close and stayed near its 52-week high during morning trade on 07 October 2026.
What is the current Zim Laboratories Share Price?
Ans. Zim Laboratories Share Price was Rs 145.20 at 1:22 PM IST on 07 October 2026. That compares with a previous close of Rs 138.5 and keeps the stock near its yearly high.
How much did Zim Laboratories Share Price move today?
Ans. Zim Laboratories Share Price moved up Rs 6.7, or 4.84%, from the previous close. The session range so far has been Rs 136.8 to Rs 152, with the stock trading near the upper end.
Is Zim Laboratories Share Price near its 52-week high?
Ans. Yes. Zim Laboratories Share Price is trading near its 52-week high according to the latest Univest data. The stock’s current trade level keeps it within sight of that yearly high zone.
What does the valuation say about Zim Laboratories Share Price?
Ans. Zim Laboratories Share Price has a P/E of 201.07 and a P/B of 2.56. The earnings multiple is far above the same-industry median, while the book multiple is slightly below the industry median.
How do the profitability ratios compare for Zim Laboratories Share Price?
Ans. Zim Laboratories Share Price shows ROE of 2.14% and ROCE of 5.47%. Both figures are below the same-industry medians, which gives important context for current ZIMLA Stock News.
What is the market capitalisation of Zim Laboratories Share Price?
Ans. Zim Laboratories Share Price has a market capitalisation of Rs 731.1 Cr. That is below the same-industry median market cap of Rs 833.16 Cr used in the sector comparison.
How does Zim Laboratories Share Price compare with peers?
Ans. Zim Laboratories Share Price has a higher P/E than the peer names shown in the comparison set. Its ROE and ROCE are also below those listed peers, which makes the valuation profile stand out.
Track Zim Laboratories Share Price on Univest
Use Zim Laboratories Ltd. (ZIMLA) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Readers tracking Zim Laboratories Share Price can follow live price movement, market cap, financial ratios, 52-week levels, peer comparisons and sector context on Univest. Zim Laboratories Share Price Today, ZIMLA Share News and Zim Laboratories Latest News are updated in a format designed for quick screening and deeper comparison across the Healthcare space.